SEC Filing Analysis: INTUITIVE SURGICAL INC (ISRG)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An Officer and Director of Intuitive Surgical has filed a notice of proposed sale for approximately $13 million worth of common stock under a pre-established 10b5-1 trading plan.
• Market Impact: The transaction is not material relative to the company's market capitalization and is unlikely to have a significant impact on the stock price.

Company Information

Field	Value
Company	INTUITIVE SURGICAL INC
Ticker Symbol	ISRG
CIK	0001035267
Industry	Orthopedic, Prosthetic & Surgical Appliances & Supplies

Insider Information

Field	Value
Name	GUTHART GARY S
CIK	0001280628
Title/Position	Officer, Director
Relationship	Officer, Director

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-12-01 (Approximate Sale Date)
Transaction Code	S (Proposed Sale)
Security Type	Common Stock
Shares Involved	22,806
Price Per Share	~$570.90 (calculated)
Total Value	$13,019,721.90
Shares Owned After	Not specified in filing
Ownership Type	Not specified in filing

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$13,019,721.90
% of Market Cap	0.0067%
Shares Transacted	22,806
% of Shares Outstanding	0.0064%
Post-Transaction Ownership	Not specified
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a mega-cap company with a market capitalization of approximately $194.8 billion, a $13 million transaction is financially immaterial.
• Ownership Concentration: The number of shares being sold is a very small fraction of the total shares outstanding, indicating no significant change in the company's ownership structure.
• Dilution Impact: Not applicable, as this is a sale of existing shares, not an issuance or option exercise.
• Transaction Significance: The sale represents less than 0.01% of both the market capitalization and the total shares outstanding. These percentages are well below the thresholds for moderate or high significance, classifying this as a routine transaction.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale is conducted under a Rule 10b5-1 trading plan, which was adopted on April 28, 2025. This indicates the sale was pre-planned and is not based on recent, non-public information. The transaction's small size relative to the company's market cap further supports a neutral outlook.

Volume & Sentiment

• Expected Volume Impact: Minimal. The proposed sale of 22,806 shares would be easily absorbed by the market, as ISRG typically has a high daily trading volume.
• Sentiment Indicator: Neutral. Pre-planned sales by long-term executives are common for financial planning and diversification and are generally not viewed as a bearish signal by the market.

Additional Context

Transaction Notes

• Special Circumstances: The filing notes this sale is pursuant to a 10b5-1 plan. The filing also discloses that the insider sold a total of 31,600 shares for approximately $17.3 million in October 2025, establishing a pattern of regular, planned dispositions.
• Market Environment: This filing occurs in the context of a stable market position for Intuitive Surgical as a leader in robotic-assisted surgery.